
    
      A randomized, double-blind, 12 week parallel dietary intervention study is conducted to
      evaluate the effects of the two novel food products containing fermented rye bran in normal
      weight and overweight men and women with prevalent HP infection. A follow-up is planned at
      week 24. The primary endpoint is severity of HP infection indicated by a breath test.
      Secondary endpoints include effects on chronic inflammation, insulin resistance, blood
      lipids, blood cholesterol,body weight, intestinal microbial clusters et al. The food products
      given to the treatment group will be a novel breakfast cereal product and a crispbread
      product containing fermented rye bran. The control product will be corresponding products
      based on refined wheat.
    
  